Skip to main content



Local Cdiff information for New Hampshire

New Hampshire

Learn about C. diff providers, regulation, clinical trials, and advocacy efforts in New Hampshire.



Local Cdiff information for New Hampshire

New Hampshire

Learn about C. diff providers, regulation, clinical trials, and advocacy efforts in New Hampshire.

Providers

Atlantic Digestive Specialists

21 Clark Way, Route 108
Somersworth, NH 03878
Phone: (603) 692-2228
FAX: (603) 692-0418

330 Borthwick Avenue, Suite 311
Portsmouth, NH 03801
Phone: (603) 433-2488
FAX: (603) 433-4237

VISIT WEBSITE

Regulation

C. diff Infections

Total Reported Cases: 342
Hospital Onset: 342
Community Onset: Not reported
Related Deaths: Not reported

Available Reports

Annual Progress based on SIR: 0.89
CDC STATE PROGRESS REPORT >
STATE REPORTING >

State Reporting Laws

Data Submission Required: No
Data Publicly Available: No
Data Validated: No
Facility-specific Data Publicly Reported: No
LTC Facility Submission Required: No
LTC Facility Data Publicly Reported: No
Law/Regulation: Not available
STATUTE >

State Contact

Roza Tammer, M.P.H.
Healthcare-Associated Infections Surveillance Coordinator
New Hampshire Department of Health and Human Services
HAI Program Bureau of Infectious Disease Control, New Hampshire Division of Public Health Services
29 Hazen Drive
Concord, 3301
(603) 271-5927
(603) 271-0545
EMAIL ROZA TAMMER, M.P.H. >

CLINICAL TRIALS

RESTORATiVE303

Official Title: A Randomized, Double-Blind, Placebo-Controlled Phase 3 Study of VE303 for Prevention of Recurrent Clostridioides Difficile Infection
Trial No. NCT06237452
Type: Interventional
Recruitment: Recruiting
Sponsor: Vedanta Biosciences, Inc
Contact: Mary Garfield
EMAIL >
Gender: All
Age: 12 Years and older
Vedanta Biosciences has teamed up with Science37 to provide a site-less, decentralized approach. This means the study can be done remotely and the product comes to you, in your home. This allows applicants who are not near a study site or unable to travel to participate and receive treatment. You can sign up for the decentralized study here.